Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹22.76
Market cap: ₹125.7 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 51.8×Sector 47.4×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 2 Annual General Meeting 2 Results Correction 1 Other Announcement 1 Management Change 1 Financial Results 1 Earnings Call 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Aug 2026 23:36 IST NSE

Management Change

Balaxi Pharmaceuticals Management Change

Balaxi Pharmaceuticals Limited shareholders approved the re-appointment of Ms. Akshita Ostwal as an Independent Director for a second five-year term starting September 5, 2026.

Read the filing ↗